Pharma

Your Article Summary

See Latest Articles

The pharmaceutical majors forward projects in biocatalysis, solvent replacement, and other approaches in green chemistry
Pharmaceutical Technology, 04/21/09

Going green by incorporating more environmentally friendly approaches to the synthesis of active pharmaceutical ingredients and intermediates can help to increase manufacturing efficiency and costs. In keeping with the fundamentals of green chemistry pharmaceutical companies are using strategies such as solvent reduction and replacement, refining a chemical route, and biocatalysis to optimize certain API syntheses while achieving improved environmental profiles.

Today in Biotechnology...keeping you current

Receive free subspecialty "5-minute updates" via email

Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09

Quality by Design for Biotechnology Products—Part 2
BioPharm, 12/09/09

Amylin Pharmaceuticals to Present at the 2009 Deutsche Bank Biotech Boston Confab
Amylin Pharmaceuticals, 12/09/09

 See all of Biotechnology